First Trust Large Cap Growth Fund logo

First Trust Large Cap Growth Fund (FTC)

Market Closed
22 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
179. 05
-0.11
-0.0593%
$
1.45B Market Cap
0.21% Div Yield
80,850 Volume
$ 179.16
Previous Close
Add Transaction
Day Range
177.56 179.94
Year Range
147.94 194.18
Want to track FTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Exclusive: FTC seeking details on Amazon deal with AI startup Adept, source says

Exclusive: FTC seeking details on Amazon deal with AI startup Adept, source says

The U.S. Federal Trade Commission has asked Amazon.com to provide more details on its deal to hire top executives and researchers from artificial intelligence startup Adept, a person familiar with the matter told Reuters.

Reuters | 2 years ago
FTC Requests More Information on $6.4B IBM Planned Acquisition of HashiCorp

FTC Requests More Information on $6.4B IBM Planned Acquisition of HashiCorp

The Federal Trade Commission (FTC) has made a "second request" for additional information around IBM's (IBM) plan to acquire cloud software company HashiCorp (HCP) for $6.4 billion.

Investopedia | 2 years ago
FTC to sue drug middlemen CVS, UnitedHealth over insulin prices: report

FTC to sue drug middlemen CVS, UnitedHealth over insulin prices: report

The agency plans to file lawsuits targeting the business practices related to rebates brokered with drug manufacturers, the Journal reported.

Nypost | 2 years ago
FTC to sue drug middlemen over prices of medications including insulin

FTC to sue drug middlemen over prices of medications including insulin

The Federal Trade Commission is planning to sue three large U.S. health companies over their practices as middlemen who negotiate prices for medications such as insulin, a source familiar with the matter told CNBC. The suits are set to target the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts, which are all owned by or connected to health insurers.

Cnbc | 2 years ago
Tempur Sealy mattress takeover hit by FTC lawsuit

Tempur Sealy mattress takeover hit by FTC lawsuit

The $4 billion takeover by bedding group Tempur Sealy International (NYSE:TPX) of Mattress Firm Group Inc is facing a legal challenge from the US antitrust agency. Overnight, the Federal Trade Commission took the deal to federal court to block the combination of the largest US mattress maker with the biggest bedding retailer.

Proactiveinvestors | 2 years ago
Gig-work company Arise settles with FTC for $7 million over ‘false promises' of pay

Gig-work company Arise settles with FTC for $7 million over ‘false promises' of pay

NEW YORK — The Federal Trade Commission is taking action against a gig-work company, saying it misled people about the money they could make on its platform.

Marketwatch | 2 years ago
FTC unanimously votes to block $4B Tempur Sealy, Mattress Firm merger

FTC unanimously votes to block $4B Tempur Sealy, Mattress Firm merger

The commission said the acquisition could hike prices for consumers, take out competitors and cut jobs at rival mattress companies.

Nypost | 2 years ago
FTC sues to block $4B merger of mattress firms

FTC sues to block $4B merger of mattress firms

The Federal Trade Commission voted to file a lawsuit to block the proposed $4 billion merger between Tempur Sealy and Mattress Firm over concerns about its competitive impact.

Foxbusiness | 2 years ago
Teva's stock falls after report FTC has opened probe of patents

Teva's stock falls after report FTC has opened probe of patents

Teva Pharmaceuticals Industries Ltd.'s stock fell 2% Monday after a report said the Federal Trade Commission has opened an investigation into the Israeli generics company, citing its refusal to take down roughly two dozen patents for its asthma and COPD inhalers.

Marketwatch | 2 years ago
FTC starts probe into Teva about some products' patents, Washington Post reports

FTC starts probe into Teva about some products' patents, Washington Post reports

The U.S. Federal Trade Commission has opened an investigation into Teva Pharmaceutical over the company's refusal to take down about two dozen patents for its asthma and COPD inhalers, the Washington Post reported on Monday, citing agency documents.

Reuters | 2 years ago
3 Stocks that Might Benefit From the FTC-Adobe Lawsuit

3 Stocks that Might Benefit From the FTC-Adobe Lawsuit

The news of the U.S. government's allegations has shaken the financial sector. Adobe is at the center of a criticism storm from the Federal Trade Commission (FTC), which claims that the company concealed the cost of canceling its subscription plan.

Investorplace | 2 years ago
FTC Alleges Adobe Deters Subscription Cancellations, Hides Early Termination Fee

FTC Alleges Adobe Deters Subscription Cancellations, Hides Early Termination Fee

The Federal Trade Commission (FTC) is taking action against Adobe and two of its executives, alleging that they deceived consumers by hiding an early termination fee on a subscription plan and making it difficult for customers to cancel their subscriptions.

Pymnts | 2 years ago
Loading...
Load More